Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial) (Q61457393)
Jump to navigation
Jump to search
article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial) |
article |
Statements
Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial) (English)
I. Poizot-Martin
Isabelle Poizot-Martin
G. Chene
Geneviève Chêne
Sébastien Gallien
Valérie Journot
Willy Rozenbaum
Patrick Yéni
Philippe Morlat
Jacques Reynes
Véronique Reliquet
Pascale Leclercq
François Simon
ALIZE (ANRS 099) Study Group
28 October 2010